𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Elevated plasma levels of TGF-β1 in patients with invasive prostate cancer

✍ Scribed by Ivanovic, Vesna; Melman, Arnold; Davis-Joseph, Brian; Valcic, Mira; Geliebter, Jan

Book ID
109928045
Publisher
Nature Publishing Group
Year
1995
Tongue
English
Weight
478 KB
Volume
1
Category
Article
ISSN
1078-8956

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Elevated serum level and gene polymorphi
Elevated serum level and gene polymorphisms of TGF-β1 in gastric cancer
✍ Xue Li; Zhi-Chao Yue; Yun-Yan Zhang; Jing Bai; Xiang-ning Meng; Jing-Shu Geng; S 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 227 KB

## Abstract Transforming growth factor (TGF)‐β1, as a candidate tumor marker, is currently of interest. In this study, serum TGF‐β1 levels in gastric cancer (GC) patients and healthy volunteers were measured using enzyme‐linked immunosorbent assay (ELISA). In addition, single nucleotide polymorphis

Elevated plasma tissue inhibitor of meta
Elevated plasma tissue inhibitor of metalloproteinase-1 levels predict decreased survival in castration-resistant prostate cancer patients
✍ William K. Oh; Roberto Vargas; Susanna Jacobus; Kim Leitzel; Meredith M. Regan; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 220 KB

## Abstract ## BACKGROUND. Tissue inhibitor of metalloproteinase‐1 (TIMP‐1) has paradoxical multifunctional roles in tumorigenesis: inhibition of the catalytic activity of matrix metalloproteinases and apoptosis as well as promotion of angiogenesis and tumor growth. Elevated TIMP‐1 levels have bee